Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Developed Markets
  • Asset Class: Equity
  • Geographic Focus: Global

Allianz Biotechnologie

+ Add to Watchlist

DJFF:GR

180.5470 EUR 5.3770 3.07%

As of 11:47:27 ET on 03/27/2015.

Snapshot for Allianz Biotechnologie (DJFF)

Open: 175.8700 High - Low: 180.5470 - 174.4000 Primary Exchange: Frankfurt
Volume: 105 52-Week Range: 93.9400 - 194.2000 Beta vs NBI: 0.9518

ETF Chart for DJFF

No chart data available.
  • DJFF:GR 180.5470
  • 1D
  • 1M
  • 1Y
175.1700
Interactive DJFF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DJFF

Allianz Biotechnologie is an open-end investment fund incorporated in Germany. The Fund's objective is growth. The Fund invests primarily in stocks, warrants and profit sharing certificates. The Fund may also invest in bonds withwarrants and convertible debentures issued by pharmaceutical and biotechnology corporations worldwide.

Inception Date: 1998-01-09 Telephone: 49-69-24431-140 Tel
Managers: -
Web Site: www.allianzglobalinvestors.de

Fundamentals for DJFF

NAV (on 2015-03-26) 175.1700
Assets (M) (on 2015-03-27) 377.0237
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium 0.00
Average 52-Week % Premium -0.5873
Fund Leveraged N

Dividends for DJFF

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -%

Performance for DJFF

1-Month +7.74% 1-Year +69.50%
3-Month +28.39% 3-Year +40.72%
Year To Date +25.90% 5-Year +27.48%
Expense Ratio 2.05

Top Fund Holdings for DJFF

Filing Date: 11/30/2014
Name Position Value % of Total
Alexion Pharmaceuticals Inc 157,710 24,691,086 7.444%
Celgene Corp 252,310 22,844,509 6.887%
Biogen Inc 88,920 21,799,963 6.572%
Vertex Pharmaceuticals Inc 223,500 20,735,576 6.252%
Medivation Inc 175,995 16,248,980 4.899%
Regeneron Pharmaceuticals Inc 45,000 15,045,588 4.536%
Amgen Inc 102,510 13,576,348 4.093%
Incyte Corp 201,500 12,152,472 3.664%
Illumina Inc 78,430 12,101,176 3.648%
Actelion Ltd 125,000 11,823,945 3.565%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil